CONGENITAL CYTOMEGALOVIRUS INFECTION
Clinical trials for CONGENITAL CYTOMEGALOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL CYTOMEGALOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for CONGENITAL CYTOMEGALOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a new drug help babies with a common but dangerous birth infection?
Disease control Recruiting nowThis early-phase study tests an oral antiviral drug called letermovir in 12 infants born with symptomatic congenital cytomegalovirus (CMV) infection. The goal is to find the right dose and see if it safely lowers the amount of virus in the body. Babies also receive standard treat…
Matched conditions: CONGENITAL CYTOMEGALOVIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to catch hidden infection in babies with hearing loss
Knowledge-focused Recruiting nowThis study collects information from 450 newborns who fail their initial hearing screening. Doctors will test them for congenital CMV, a common infection that can cause hearing loss and other problems. The goal is to see how often CMV is found and to improve follow-up care for af…
Matched conditions: CONGENITAL CYTOMEGALOVIRUS INFECTION
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC